Stock market Updates | Themis Medicare Ltd. | R Wadiwala Securities Pvt Ltd

THEMIS MEDICARE LTD.

NSE : THEMISMEDBSE : 530199ISIN CODE : INE083B01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE236.85-3.4 (-1.42 %)
PREV CLOSE (Rs.) 240.25
OPEN PRICE (Rs.) 251.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4787
TODAY'S LOW / HIGH (Rs.)235.30 251.95
52 WK LOW / HIGH (Rs.)109 253.9
NSE236.50-4.55 (-1.89 %)
PREV CLOSE( Rs. ) 241.05
OPEN PRICE (Rs.) 243.85
BID PRICE (QTY) 236.50 (450)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 77046
TODAY'S LOW / HIGH(Rs.) 235.00 243.85
52 WK LOW / HIGH (Rs.)109.64 254

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
11.39
Dividend Yield(%)
0.21
TTM EPS (Rs.)
3.01
P/E Ratio
78.71
Book Value (Rs.)
32.45
Face Value (Rs.)
1
MCap (Rs. in Mn)
21799.70
Price/Earning (TTM)
54.93
Price/Sales (TTM)
5.99
Price/Book (MRQ)
7.30
PAT Margin (%)
12.22
ROCE (%)
19.68
company info
Incorporation Year : 31-05 1969

Management Info :

Dinesh S Patel - Chairman Sachin D Patel - Managing Director

Registered Office :

Address : Plot No 69 A,G I D C Industrial Estate, ,
Vapi,
Gujarat-396195

Phone : 0260-2431447/ 2430219

Registrars Details :

Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
News
10Nov Themis Medicare launches novel Opioid
Themis Medicare has launched a novel Opioid Injectable Analgesic Remifen..
06Nov Themis Medicare informs about newspape
In terms of Regulations 47 of the SEBI Listing Regulations, Themis Medic..
17Oct Themis Medicare informs about newspape
In terms of Regulation 47 of the SEBI Listing Regulations, Themis Medica..
Financials
QTR Dec 23 ANNUAL 23
Net Profit20.01432.94
Gross Profit 28.52 589.08
Operating Profit 86.33 789.67
Net Sales 825.13 3543.23
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
NGL Fine-Chem (BSE)
Rwadiwala-peer-arrow  2174.05 (2.26%)
M.Cap (Rs. in Cr)1343.13
Astrazeneca Pharma I (BSE)
Rwadiwala-peer-arrow  5495.90 (0.60%)
M.Cap (Rs. in Cr)13739.75
RPG Life Sciences (BSE)
Rwadiwala-peer-arrow  1660.40 (1.91%)
M.Cap (Rs. in Cr)2746.14
Windlas Biotech (BSE)
Rwadiwala-peer-arrow  546.65 (5.60%)
M.Cap (Rs. in Cr)1136.95
Shareholding Pattern
PROMOTERS
67.16%
NON-INSTITUTION
32.82%
FI/BANKS/INSURANCE
0.01%
MUTUAL FUNDS/UTI
0%
GOVERNMENT
0%
FII
0%
Mf Holdings
Scheme Name
Hold(%)